000 01299 a2200337 4500
005 20250513110715.0
264 0 _c19970401
008 199704s 0 0 eng d
022 _a0074-7742
024 7 _a10.1016/s0074-7742(08)60720-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMcBurney, R N
245 0 0 _aDevelopment of the NMDA ion-channel blocker, aptiganel hydrochloride, as a neuroprotective agent for acute CNS injury.
_h[electronic resource]
260 _bInternational review of neurobiology
_c1997
300 _a173-95 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcute Disease
650 0 4 _aBrain Injuries
_xdrug therapy
650 0 4 _aCerebrovascular Disorders
_xdrug therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrugs, Investigational
_xchemistry
650 0 4 _aGlasgow Coma Scale
650 0 4 _aGuanidines
_xpharmacology
650 0 4 _aHumans
650 0 4 _aN-Methylaspartate
_xantagonists & inhibitors
650 0 4 _aNeuroprotective Agents
_xchemistry
650 0 4 _aReference Values
650 0 4 _aSpinal Cord Injuries
_xdrug therapy
773 0 _tInternational review of neurobiology
_gvol. 40
_gp. 173-95
856 4 0 _uhttps://doi.org/10.1016/s0074-7742(08)60720-5
_zAvailable from publisher's website
999 _c8981032
_d8981032